AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Diormin V 1mg/500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Astam Health Care Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Diormin V 1mg/500mg/0.2mg Tablet SR

Diabetic patients may find relief with the anti-diabetic medication, Diormin V 1mg/500mg/0.2mg SR Tablet. This combination drug effectively manages type 2 diabetes in adults by regulating blood glucose. Administer this medication orally with food, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, Diormin V is only one component of a comprehensive diabetes management plan, requiring adherence to a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Carry a fast-acting sugar source (e.g., fruit juice) to counter this. Alcohol consumption should be limited due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiac issues should inform their doctor prior to commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are essential.

Uses of Diormin V 1mg/500mg/0.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Diormin V 1mg/500mg/0.2mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Diormin V 1mg/500mg/0.2mg Extended-Release tablets should be taken on an empty stomach.

Common Side effects of Diormin V 1mg/500mg/0.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Diormin V 1mg/500mg/0.2mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Diormin V 1mg/500mg/0.2mg Extended-Release tablets on an empty stomach.

How Diormin V 1mg/500mg/0.2mg Tablet SR works:

Extended-release Diormin V tablets (1mg/500mg/0.2mg) contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Diormin V 1mg/500mg/0.2mg SR tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Diormin V 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Diormin V 1mg/500mg/0.2mg tablet likely poses a risk during lactation. Preliminary human evidence indicates potential transfer to breast milk, possibly endangering the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Diormin V 1mg/500mg/0.2mg SR tablets is likely unsafe for individuals with kidney impairment and should be forgone. Medical advice is essential. Furthermore, its administration is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Diormin V 1mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate hepatic dysfunction, initiation should be at a reduced dosage; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Diormin V 1mg/500mg/0.2mg Tablet SR :

Should you forget a Diormin V 1mg/500mg/0.2mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Diormin V 1mg/500mg/0.2mg Tablet SR

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Diormin V 1mg/500mg/0.2mg Tablet SR

Diormin V 1mg/500mg/0.2mg Extended-Release tablets contain glimepiride, metformin, and voglibose. This triple-drug formulation manages type 2 diabetes mellitus by regulating blood sugar in adults. Its effectiveness is enhanced by a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin decreases hepatic glucose production and improves insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal glucose elevations. This medication is unsuitable for type 1 diabetes.
Diormin V 1mg/500mg/0.2mg SR tablets may cause common adverse reactions including low blood glucose, gastrointestinal upset (such as nausea, diarrhea, and flatulence), altered taste perception, abdominal pain, headache, skin eruptions, and respiratory illness.
Patients with hypersensitivity to Diormin V 1mg/500mg/0.2mg Tablet SR components or inactive ingredients should not take this medication. Its use is contraindicated in individuals with moderate to severe nephropathy, inflammatory bowel disorders, colonic ulcers, and underlying metabolic acidosis, such as diabetic ketoacidosis.
Combining Diormin V 1mg/500mg/0.2mg SR tablets with alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and raises the likelihood of lactic acidosis.
Diormin V 1mg/500mg/0.2mg SR tablets can induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. These symptoms are more likely if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are concurrently used. Consequently, consistent blood glucose monitoring is crucial. Readily available glucose tablets, honey, or fruit juice should always be kept on hand.
Retain this medication within its original, sealed packaging. Follow the storage directions provided on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Diormin V 1mg/500mg/0.2mg...
49
MRP 60
18% off